Potentiating_effect_of_ribavirin_on_the_in_vitro_and_in_vivo_antiretrovirus_activities_of_2',3'-dideoxyinosine_and_2',3'-dideoxy-2,6-diaminopurine_riboside._2',3'-Dideoxyinosine_(DDI)_and_2',3'-dideoxy-2,6-diaminopurine_riboside_(ddDAPR)_are_potent_and_selective_inhibitors_of_human_immunodeficiency_virus_(HIV)_replication_in_MT-4_cells._They_are_also_inhibitory_to_the_transformation_of_C3H/3T3_cells_by_Moloney_murine_sarcoma_virus_(MSV)._In_vivo,_they_are_only_marginally_effective_in_delaying_MSV-induced_tumor_formation,_and_mortality_associated_therewith_in_newborn_NMRI_mice._When_combined_with_ribavirin,_DDI_and_ddDAPR_become_much_more_effective_in_inhibiting_MSV_and_HIV_replication_in_vitro_and_MSV-induced_tumor_formation_in_vivo._These_observations_point_to_the_potential_role_of_ribavirin_in_potentiating_the_anti-HIV_activity_of_DDI_in_AIDS_patients.